🔎 Trials Near Me

홈 › 비만 › 버지니아

버지니아의 비만 임상 시험

비만 관련 연구 44개가 버지니아 내 여러 지역에서 참여자를 모집하고 있습니다.

버지니아의 도시

공식 연구 텍스트(영어)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

  • Washington Center For Weight Management And Research /ID# 282047, Arlington
  • Sovah Health - Danville /ID# 282876, Danville
  • Health Research Of Hampton Roads /ID# 282014, Newport News
  • 외 1개
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07752979

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • Washington Cntr Weight Mgmt, Arlington
  • Health Res of Hampton Roads, Newport News
  • National Clin Res Inc., Richmond
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  • National Clin Res Inc., Richmond
  • Gastroent Consult of SW VA, Roanoke
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07668414

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • York Clinical Research, LLC, Norfolk
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07595549

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

  • Washington Cntr Weight Mgmt, Arlington
  • Health Res of Hampton Roads, Newport News
  • Selma Medical Associates, Winchester
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07339423

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • VCU Health - Center for Endocrinology Diabetes and Metabolism, Richmond
피험자 모집 중3상
6세 ~ 17세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Gastroenterology Consultants of Southwest Virginia, Roanoke
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06937086

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • Sovah Clinical Research-River District, Danville
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07589608

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Carient Heart & Vascular - Manassas, Manassas
  • Carient Heart and Vascular LLC-Reston, Reston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07783802

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

  • Charlottesville Medical Research, Charlottesville
  • Gershon Pain Specialists, Virginia Beach
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07153471

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Manassas
  • Research Site, Norfolk
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07784270

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • Charlottesville Medical Research, Charlottesville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07353931

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • AMR Clinical, Norfolk
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07321886

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Inova Cardiology - Fairfax, Fairfax
  • Virginia Heart, Falls Church
피험자 모집 중3상
45세 ~ 99세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07037433

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Hampton
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Hampton
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Conquest Research, LLC, Arlington
  • Virginia Heart, Falls Church
  • Carient Heart and Vascular, Manassas
  • 외 2개
피험자 모집 중3상
18세 ~ 99세 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Manassas Clinical Research Center, Manassas
  • Centricity Research Suffolk Primary Care, Suffolk
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Burke
  • ACCOMPLISH-2 Research Site, Manassas
  • ACCOMPLISH-2 Research Site, Suffolk
피험자 모집 중3상건강한 지원자 환영
18세 ~ 79세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

  • Selma Medical Associates, Winchester
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07770841

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • Eastern Virginia Medical School (EVMS) Medical Group, Norfolk
  • Clinical Research Partners, LLC, Richmond
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07215559

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

  • Sovah Clinical Research-River District, Danville
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06143956

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  • National Clin Res Inc., Richmond
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07533175

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

  • Health Res of Hampton Roads, Newport News
  • National Clin Res Inc., Richmond
  • Selma Medical Associates, Winchester
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07745504

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

  • Kailera Clinical Site, Danville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • Manassas Clinical Research Center Inc, Manassas
피험자 모집 중3상
18세 ~ 99세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07684144

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, Manassas
  • Kailera Clinical Site, Richmond
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Washington Center for Weight Management and Research, Inc, Arlington
  • Health Research of Hampton Roads, Newport News
  • Selma Medical Associates, Winchester
피험자 모집 중3상
18세 ~ 99세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07684235

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

  • Kailera Clinical Site, Manassas
  • Kailera Clinical Site, Richmond
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT07284979

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  • Research Site, Arlington
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT07784725

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • University Of Virginia Hospital, Charlottesville
  • Carient Heart and Vascular, Manassas
  • TPMG Clinical Research, Newport News
  • 외 4개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07567001

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  • Health Res of Hampton Roads, Newport News
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT07509307

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

  • Charlottesville Medical Research, Charlottesville
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT07477704

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  • Charlottesville Med Research, Charlottesville
  • Health Res of Hampton Roads, Newport News
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 7. 9. 업데이트됨 · NCT07481630

Brief Inhibitory Training for Eating - Intervention

  • George Mason University, Fairfax
피험자 모집 중
14세 ~ 17세 · 모든 성별 · 2026. 6. 17. 업데이트됨 · NCT07592728

Advancing Water Security: A Community Participatory School-Based Hydration Intervention

  • Children's Hospital of Richmond at VCU Healthy Lifestyles Center, Henrico
피험자 모집 중건강한 지원자 환영
4세 이상 · 모든 성별 · 2026. 6. 10. 업데이트됨 · NCT06714929

Redefining BMI: The Body, Mind, and Inflammation Trial

  • Virginia Commonwealth Universtity, Richmond
피험자 모집 중
18세 ~ 25세 · 여성 · 2026. 5. 6. 업데이트됨 · NCT06532747

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

  • Vanda Investigational Site, Burke
피험자 모집 중3상건강한 지원자 환영
18세 ~ 65세 · 모든 성별 · 2026. 4. 20. 업데이트됨 · NCT07446439

Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy

  • University of Virginia Medical Center, Charlottesville
피험자 모집 중2상
12세 ~ 21세 · 모든 성별 · 2026. 4. 17. 업데이트됨 · NCT06903923

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.